JPRN-UMIN000007589已完成2 期
A feasibility study of neoadjuvant Oxaliplatin and S-1 for clinical T3 or T4 gastric cancer - A feasibility study of neoadjuvant Oxaliplatin and S-1 for clinical T3 or T4 gastric cancer
ational Cancer Center0 个研究点目标入组 42 人开始时间: 2012年3月31日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Enhanced abdominal CT revealed no Bulky lymph node (>=3cmx1 or >=1.5cmx2). 2)No coagulation disorder. 3)Body temperature >=38 centigrade at the time of enrollment. 4) Active bacterial or fungal infection. 5) Interstitial pneumonia, pulmonary fibrosis, or severe emphysema. 6) History of hypersensitivity to L-OHP, Fluorouracil, Tegafur, Gimeracil, Oteracilo Potassium, Dexamethason,or 5-HT3 receptor antagonist. 7) Peripheral motor neuropathy or peripheral sensory neuropathy by any reason. 8) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ or mucosal cancer. 9) Under treatment with flucytosine, phenytoin, or warfarin. 10) Women during pregnancy or breast-feeding. 11) Severe mental disease. 12) Under treatment with systemic steroid. 13) Uncontrollable diabetes mellitus or routine administration of insulin. 14) Uncontrollable hypertension. 15) Active gastrointestinal bleeding. 16) Past history of myocardial infarction or unstable angina pectoris within 6 months. 17) HBs antigen positive.
研究者
相似试验
进行中（未招募）
1 期
Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction.ocally advanced carcinoma (squamous or adenocarcinoma) of the esophago-gastric junction Siewert type I and IIMedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 100000004864EUCTR2013-001630-18-ITIstituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione G.Pascale”40
进行中（未招募）
1 期
Phase 2 trial of neo-adjuvant Oxaliplatin and 5-fluorouracil in oesophageal cancer - Oxali/5FU in Oesophageal CancerOperable oesophageal cancerEUCTR2005-001834-34-GBOxford Radcliffe Hospitals NHS Trust
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
进行中（未招募）
2 期
KSCC1801Gastric cancerJPRN-jRCTs071180001Saeki Hiroshi25
已完成
2 期
Phase II study of S-1 and oxaliplatin as neoadjuvant chemotherapy for locally advanced adenocarcinoma of the gastric or esophagogastric junction(KSCC 1601)Gastric cancer Esophagogastric junction cancerJPRN-UMIN000021061Kyushu Study group of Clinical Cancer47